| 74.64 0.91 (1.23%) | 06-04 14:28 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 88 | 1-year : | 102.79 |
| Resists | First : | 75.34 | Second : | 88 |
| Pivot price | 71.41  |
|||
| Supports | First : | 68.52 |
Second : | 64.3 |
| MAs | MA(5) : | 74.4 |
MA(20) : | 70.65 |
| MA(100) : | 64.48 |
MA(250) : | 60.93 |
|
| MACD | MACD : | 2.3 |
Signal : | 2.1 |
| %K %D | K(14,3) : | 91.6 |
D(3) : | 93.6 |
| RSI | RSI(14): 68 |
|||
| 52-week | High : | 75.34 | Low : | 50.41 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.[ KOMP ] has closed below upper band by 24.0%. Bollinger Bands are 101.6% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 5 days. This is a sign that the current trend might continue.
| If tomorrow: | Open lower | Open higher |
| High: | 74.72 - 75.09 | 75.09 - 75.45 |
| Low: | 72.55 - 73.01 | 73.01 - 73.46 |
| Close: | 72.91 - 73.64 | 73.64 - 74.36 |
T
Thu, 04 Jun 2026
State Street SPDR S&P Pharmaceuticals vs First Trust NYSE Arca Biotech: Which Is the Better ETF For Your Portfolio? - The Motley Fool
Wed, 03 Jun 2026
Should you invest in the State Street SPDR S&P Pharmaceuticals ETF (XPH)? - MSN
Tue, 02 Jun 2026
Is State Street SPDR S&P Aerospace & Defense ETF (XAR) a Strong ETF Right Now? - Yahoo Finance
Sat, 30 May 2026
State Street SPDR S&P North American Natural Resources ETF To Go Ex-Dividend On June 1st, 2026 With 0.71278 USD Dividend Per Share - Moomoo
Fri, 29 May 2026
State Street SPDR S&P 500 ETF Trust Reports Earnings Results for the Half Year Ended March 31, 2026 - marketscreener.com
Fri, 29 May 2026
Is State Street SPDR S&P Semiconductor ETF (XSD) a Strong ETF Right Now? - Yahoo Finance
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
AMEX
|
|
|
Sector:
Financial Services
|
|
|
Industry:
Asset Management - Global
|
|
| Shares Out | 0 (M) |
| Shares Float | 0 (M) |
| Held by Insiders | 0 (%) |
| Held by Institutions | 0 (%) |
| Shares Short | 0 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | 0 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0 |
| Profit Margin | 0 % |
| Operating Margin | 0 % |
| Return on Assets (ttm) | 0 % |
| Return on Equity (ttm) | 0 % |
| Qtrly Rev. Growth | 0 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0 |
| EBITDA (p.s.) | 0 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | 0 (M) |
| PE Ratio | 0 |
| PEG Ratio | 0 |
| Price to Book value | 0 |
| Price to Sales | 0 |
| Price to Cash Flow | 0 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|